Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 15, Number 25, 2009

Articles

Favourites:
ADD

Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
pp. 2869-2883(15)
Authors: Vitek, Libor; Ostrow, J. D.

Favourites:
ADD

The Role of ABC Transporters in Protecting Cells from Bilirubin Toxicity
pp. 2884-2892(9)
Authors: Bellarosa, C.; Bortolussi, G.; Tiribelli, C.

Favourites:
ADD

Blood-Brain Interfaces and Bilirubin-Induced Neurological Diseases
pp. 2893-2907(15)
Authors: Ghersi-Egea, J. F.; Gazzin, S.; Strazielle, N.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Pharmacological Therapies for Unconjugated Hyperbilirubinemia
pp. 2927-2938(12)
Authors: Cuperus, F.J. C.; Hafkamp, A. M.; Hulzebos, C. V.; Verkade, H. J.

Favourites:
ADD

Intervention Guidelines for Neonatal Hyperbilirubinemia: An Evidence Based Quagmire
pp. 2939-2945(7)
Authors: Wennberg, Richard P.; Ahlfors, Charles E.; Aravkin, Aleksandr Y.

Favourites:
ADD
Favourites:
ADD

Dendrimers: A Class of Polymers in the Nanotechnology for the Delivery of Active Pharmaceuticals
pp. 2958-2969(12)
Authors: Samad, Abdus; Alam, Md. I.; Saxena, Kinshuk

Favourites:
ADD

Hybrid Drugs for Malaria
pp. 2970-2985(16)
Authors: Walsh, J. J.; Bell, A.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content